Revvity Inc (RVTY) Stock Price, Quote & News

Company Profile

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 663 6900

Website: www.revvity.com

Address:

77 4th Avenue, Waltham, United States

YouOnlyLiveTwice Mar. 11 at 8:16 PM

$RVTY Why TF would anyone even commit a$1 to this company They go to 3 conferences no mention of any new partnerships , no update on guidance just whining about how the misconception of Cluade meanwhile this incompetent CEO who should go back to being a scientist is making $3.7M per year The top 5 people in this company make collectively over $10M per year and look at the results down well over 25% for the year

0 · Reply

YouOnlyLiveTwice Mar. 10 at 6:49 PM

$RVTY The CEO and CFO have spoken 4x in the last 6 weeks and the stock has crashed 28 points ….thats all you need to know about this company CPOS

0 · Reply

YouOnlyLiveTwice Mar. 10 at 2:07 PM

$RVTY The CEO of this company makes over $3M per year in just salary Look at the stock performance over the last 3 years a complete disaster He should be fired as well as the BOD for paying him this amount of $$ ..

0 · Reply

YouOnlyLiveTwice Mar. 10 at 1:39 PM

$RVTY Another useless conference today. They go and say the same thing they said weeks ago during the ER call Every time he speaks expect the stock to go down If you don’t have anything “NEW” then don’t go and waste peoples time

0 · Reply

YouOnlyLiveTwice Mar. 6 at 7:07 PM

$RVTY At the conference on Wednesday that idiot CEO said there maximizing shareholder value … Really based on this 5 year chart? Really bid amazing how blind the BOD is

0 · Reply

YouOnlyLiveTwice Mar. 6 at 3:06 PM

$RVTY Sell the company and take your shareholders out of misery… CEO and CFO need to be fired

0 · Reply

YouOnlyLiveTwice Mar. 5 at 6:18 PM

$RVTY I don’t know why this idiotic CEO went to the conference on Wednesday…he basically said the same thing he said on the ER call then whine about his stock value. The messaging gets an F

0 · Reply

ZacksResearch Mar. 4 at 2:21 PM

$RVTY holding steady — but not without crosscurrents ⚖️ Strong diagnostics demand and fast-growing Signals software are driving momentum. At the same time, China policy pressure and weak research spending are tempering near-term growth. Is this a smart hold right now? Get the full risk/reward view here 👉 https://www.zacks.com/stock/news/2878573/heres-why-you-should-retain-revvity-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2878573-teaser-35874&ADID=SYND_STOCKTWITS_TWEET_2_2878573_TEASER_35874

0 · Reply

ZacksResearch Mar. 4 at 1:21 PM

$RVTY riding high with a 12% gain in 6 months, but is it sustainable? 📈 Revvity's Diagnostics and AI-driven software segments show strong momentum, with a 7% organic growth in diagnostics in Q4 2025 and high-teens growth in software in 2025. However, caution looms with muted 2026 growth outlook and China’s policy woes. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2878573/heres-why-you-should-retain-revvity-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2878573-body-35872&ADID=SYND_STOCKTWITS_TWEET_2_2878573_BODY_35872

0 · Reply

YouOnlyLiveTwice Mar. 3 at 6:25 PM

$RVTY When this pattern forms the stock usually rallies …last time 15 points

0 · Reply

Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 3, 2026, 5:12 PM EST - 14 days ago

Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 9:57 AM EST - 15 days ago

Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Feb 17, 2026, 8:00 AM EST - 4 weeks ago

Revvity to Present at Upcoming Investor Conferences

Feb 5, 2026, 8:00 AM EST - 5 weeks ago

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

Feb 3, 2026, 1:35 PM EST - 6 weeks ago

Revvity: Close To A Buy, Not Quite There

Feb 3, 2026, 9:20 AM EST - 6 weeks ago

Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results

Feb 2, 2026, 12:30 PM EST - 6 weeks ago

Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript

Feb 2, 2026, 10:28 AM EST - 6 weeks ago

Revvity Sees Steady Growth On Rising Demand From Pharma/Biotech Customers

Feb 2, 2026, 7:13 AM EST - 6 weeks ago

Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Feb 2, 2026, 6:00 AM EST - 6 weeks ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

Jan 26, 2026, 4:05 PM EST - 7 weeks ago

Revvity Board Declares Quarterly Dividend

Jan 21, 2026, 1:33 PM EST - 7 weeks ago

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

BIO CABO CDW CNC EXPE FCNCA LKQ

Jan 13, 2026, 2:56 PM EST - 2 months ago

Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 5:51 AM EST - 2 months ago

Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads.

Jan 12, 2026, 5:10 PM EST - 2 months ago

Revvity says it will exceed 2025 profit forecast range

Jan 12, 2026, 4:15 PM EST - 2 months ago

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Jan 9, 2026, 8:00 AM EST - 2 months ago

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Dec 18, 2025, 8:00 AM EST - 3 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 3 months ago

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

Dec 2, 2025, 12:53 PM EST - 3 months ago

Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 18, 2025, 11:38 AM EST - 4 months ago

Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 10, 2025, 10:11 AM EST - 4 months ago

Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 10, 2025, 8:00 AM EST - 4 months ago

Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy

Nov 10, 2025, 7:45 AM EST - 4 months ago

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Oct 28, 2025, 9:32 AM EDT - 5 months ago

Revvity Analysts Increase Their Forecasts After Q3 Earnings

Oct 27, 2025, 12:56 PM EDT - 5 months ago

Revvity: Software Momentum And Screening Offset China Weakness

Oct 27, 2025, 12:47 PM EDT - 5 months ago

Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript

Oct 27, 2025, 7:06 AM EDT - 5 months ago

Revvity lifts annual profit forecast on renewed demand in diagnostics unit

Oct 27, 2025, 6:00 AM EDT - 5 months ago

Revvity Announces Financial Results for the Third Quarter of 2025

Oct 14, 2025, 8:00 AM EDT - 5 months ago

Revvity Showcases Progress with Purpose in 2025 Impact Report

Oct 6, 2025, 8:00 AM EDT - 5 months ago

Revvity to Hold Earnings Call on Monday, October 27, 2025

Oct 2, 2025, 8:00 AM EDT - 5 months ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

SNY

Sep 29, 2025, 8:00 AM EDT - 6 months ago

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

Sep 22, 2025, 8:00 AM EDT - 6 months ago

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Sep 9, 2025, 5:31 PM EDT - 6 months ago

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 3, 2025, 10:40 AM EDT - 6 months ago

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 2, 2025, 8:00 AM EDT - 7 months ago

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Aug 6, 2025, 8:00 AM EDT - 7 months ago

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Jul 28, 2025, 2:47 PM EDT - 8 months ago

Revvity Q2: Headwinds From China And Customers, Buy On Weakness

Jul 28, 2025, 1:40 PM EDT - 8 months ago

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

Jul 28, 2025, 12:25 PM EDT - 8 months ago

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

LNG NKE

Jul 28, 2025, 11:59 AM EDT - 8 months ago

Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 8:13 AM EDT - 8 months ago

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

ATAI

Jul 28, 2025, 8:09 AM EDT - 8 months ago

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

Jul 28, 2025, 7:39 AM EDT - 8 months ago

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

Jul 28, 2025, 6:00 AM EDT - 8 months ago

Revvity Announces Financial Results for the Second Quarter of 2025

Jul 7, 2025, 8:00 AM EDT - 9 months ago

Revvity to Hold Earnings Call on Monday, July 28, 2025

Jun 2, 2025, 8:00 AM EDT - 10 months ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

May 19, 2025, 8:00 AM EDT - 10 months ago

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

YouOnlyLiveTwice Mar. 11 at 8:16 PM

0 · Reply

YouOnlyLiveTwice Mar. 10 at 6:49 PM

$RVTY The CEO and CFO have spoken 4x in the last 6 weeks and the stock has crashed 28 points ….thats all you need to know about this company CPOS

0 · Reply

YouOnlyLiveTwice Mar. 10 at 2:07 PM

0 · Reply

YouOnlyLiveTwice Mar. 10 at 1:39 PM

0 · Reply

YouOnlyLiveTwice Mar. 6 at 7:07 PM

$RVTY At the conference on Wednesday that idiot CEO said there maximizing shareholder value … Really based on this 5 year chart? Really bid amazing how blind the BOD is

0 · Reply

YouOnlyLiveTwice Mar. 6 at 3:06 PM

$RVTY Sell the company and take your shareholders out of misery… CEO and CFO need to be fired

0 · Reply

YouOnlyLiveTwice Mar. 5 at 6:18 PM

$RVTY I don’t know why this idiotic CEO went to the conference on Wednesday…he basically said the same thing he said on the ER call then whine about his stock value. The messaging gets an F

0 · Reply

ZacksResearch Mar. 4 at 2:21 PM

0 · Reply

ZacksResearch Mar. 4 at 1:21 PM

0 · Reply

YouOnlyLiveTwice Mar. 3 at 6:25 PM

$RVTY When this pattern forms the stock usually rallies …last time 15 points

0 · Reply

YouOnlyLiveTwice Mar. 3 at 3:06 PM

$RVTY Down 27 points once their last WR weeks ago …. They have a conference today so the CEO will be speaking g expect more damage …amazing how blind the BOD is very sad for employees and shareholders

0 · Reply

YouOnlyLiveTwice Mar. 3 at 2:49 PM

$RVTY This is what happens when you have a horrible CFO and CEO Everytime they open their mouth the stock crashes Time to unload this garbage

0 · Reply

Streetdilly1 Mar. 3 at 12:59 AM

$FLGT why wouldnt illumina $ILMN or revity $RVTY bid $20 and take the other $6 a share in cash for free +get revenues, platform etc for free.

3 · Reply

YouOnlyLiveTwice Feb. 26 at 4:30 PM

$RVTY If you’re wondering why this is down 23 points since their earnings call BTW was an impressive beat and raise listen to dumb and dumber CEO and CFO must on the conference call they can turn a wedding into a funeral …they need to go …it’s a shame bec this company has great products

0 · Reply

YouOnlyLiveTwice Feb. 25 at 3:13 PM

$RVTY This was at $118 before the ER which was a beat and raise then the CEO who is hard to understand and the CFO who screams opened their mouths …. When is the BOD going to get rid of these clowns?

0 · Reply

YouOnlyLiveTwice Feb. 24 at 3:55 PM

$RVTY This has been thrown into the “sell the software “ story which is nonsense 3 conferences coming up start loading

0 · Reply

YouOnlyLiveTwice Feb. 17 at 5:43 PM

$RVTY This one has been a disaster for me Down now 24 points since they reported a BEAT and RAISE both revenue and eps Don’t know if it’s being dumped into the “software” sell

0 · Reply

YouOnlyLiveTwice Feb. 17 at 2:20 PM

$RVTY 3 conference’s coming up ….

0 · Reply

YouOnlyLiveTwice Feb. 12 at 4:00 PM

$RVTY Down over 20% since earnings which btw were VG They have great products and a fortress balance sheet The CEO and CFO need to go the messaging is awful

0 · Reply

Estimize Feb. 11 at 3:03 PM

Wall St is expecting 1.03 EPS for $RVTY Q1 [Reporting 05/04 BMO] http://www.estimize.com/intro/rvty?chart=historical&metric_name=eps&utm_co

0 · Reply

YouOnlyLiveTwice Feb. 6 at 3:43 PM

$RVTY Time to go all in

0 · Reply

SuperGreenToday Feb. 5 at 6:13 PM

$RVTY Share Price: $99.92 Contract Selected: Sep 18, 2026 $100 Calls Buy Zone: $10.79 – $13.33 Target Zone: $18.72 – $22.88 Potential Upside: 64% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Market Cap	9.57B
Revenue (ttm)	2.86B
Net Income (ttm)	241.20M
EPS (ttm)	N/A
PE Ratio	16.88
Forward PE	15.83
Profit Margin	8.45%
Debt to Equity Ratio	0.44

Volume	929,048
Avg Vol	1,418,210
Day's Range	N/A - N/A
Shares Out	111.80M
Stochastic %K	19%
Beta	1.10
Analysts	Sell
Price Target	$119.40